Bioabsorbable Stents Market – Global Market Size, Strategic Growth Drivers, Risk Assessment Framework, Regulatory Landscape Review, Competitive Intensity Mapping & Long-Term Industry Outlook to 2029

7.35%
CAGR (2023-2029)
323.82 USD Mn.
Market Size
300
Report Pages
160
Market Tables

Overview

Global Bioabsorbable Stents Market size is expected to reach US$ 532.02 Mn. by year 2029 at a CAGR of 7.35% during the forecast period.

The report includes the analysis of impact of COVID-19 lock-down on the revenue of market leaders, followers, and disrupters. Since lock down was implemented differently in different regions and countries, impact of same is also different by regions and segments. The report has covered the current short term and long term impact on the market, same will help decision makers to prepare the outline for short term and long term strategies for companies by region.Bioabsorbable Stents MarketTo know about the Research Methodology:-Request Free Sample Report

Global Bioabsorbable Stents Market Dynamics:

The bioabsorbable stents are the devices inserted into the blood vessel and other internal vessels to check a blockage. These stents are made up of materials may be absorbed or dissolved in the body.

The major driving factors of the global market are increasing in the incidence of cardiac diseases, the risk of coronary artery & peripheral artery diseases in the elderly population, and number of heart failure and diabetes cases. Additionally, strong product pipelines, rising technological advancements, and increasing diabetic population also drives the market growth. Rising demand from emerging economies as well as high-risk patients is a key opportunity for bioabsorbable stents market growth. Further, rising healthcare expenditure in the emerging countries are also a major opportunity for bioabsorbable stents market.

Some challenges of the global market are the availability of substitute, increasing R&D activities for the cell transplantation to treat the heart, a stringent guideline for authorization of devices, and growing competition among vendors. Slow adoption rate, stringent government regulations, and the high cost of devices are hampering the global bioabsorbable stents market growth.

The  market is segmented into absorption rates, drugs, applications, end users, materials, and region. The bio absorbable stents market based on absorption rates includes slow absorption stents and fast absorption stents. In terms of the drugs, the market is classified into paclitaxel, and limus based drugs. Based on the bioabsorbable stents market, applications segment is divided into coronary artery disease and peripheral artery disease.

Global Market Regional Analysis:

In terms of an end users,market is categorized into hospitals and cardiac centers. Further, bioabsorbable stents market based on materials includes polymeric stents and metallic stents. Based on regions, the global market is divided into five main regions are America, Europe, Asia-pacific, Latin America and Middle East & Africa. By end use, the hospital segment dominated the market during in terms of revenue and will continue to lead until the end of the forecast period due to the advanced medical infrastructure and trained professionals to cater to the needs of people, which are not usually seen in cardiac centers and small clinics.

In terms of material, polymeric bioabsorbable stents are widely used in cardiovascular devices. Polymers used in bioabsorbable stents are Poly-L-Lactic acid, Poly copolymer, Polyglycolic Acid, and polycaprolactone. Polymeric stents market is anticipated to grow at a faster rate. Usage of bioabsorbable polymer coating reduces the need for extended dual antiplatelet therapy and reduces thrombotic events. Poly-L-Lactic acid is widely used in medicine and breaks down lactic acid into natural metabolites in the human body.

Based on application, the coronary artery diseases accounted for xx % largest share of the market, due to the increasing population prone to coronary artery diseases and the adoption of unhealthy lifestyle habits leading to increased risk of these diseases.

Geographically, The Asia-Pacific market is anticipated to the fastest-growing region for the bioabsorbable stent market, due to the growing population of the geriatric people as well as the increasing awareness among people about the procedure and the products in the region. Rapidly developing healthcare infrastructure, medical tourism, and a growing geriatric population is some of the major factors that are driving the growth of the bioabsorbable stents market in the region.

The objective of the report is to present comprehensive analysis of Global Bioabsorbable Stents Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of industry with dedicated study of key players that includes market leaders, followers and new entrants by region.

PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by region on the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give clear futuristic view of the industry to the decision makers. The report also helps in understanding Global market dynamics, structure by analyzing the market segments, and project the Global  Market size. Clear representation of competitive analysis of key players by Global Bioabsorbable Stents type, price, financial position, product portfolio, growth strategies, and regional presence in the Global market make the report investor’s guide.

Global Bioabsorbable Stents Market, Key Highlights:

Global market analysis and forecast, in terms of value.

Comprehensive study and analysis of market drivers, restraints and opportunities influencing the growth of the Global Bioabsorbable Stents Market

Global market segmentation on the basis of type, source, end-user, and region (country-wise) has been provided.

Bioabsorbable Stents Market strategic analysis with respect to individual growth trends, future prospects along with the contribution of various sub-market stakeholders have been considered under the scope of study.

Global Bioabsorbable Stents Market analysis and forecast for five major regions namely North America, Europe, Asia Pacific, the Middle East & Africa (MEA) and Latin America along with country-wise segmentation.

Profiles of key industry players, their strategic perspective, market positioning and analysis of core competencies are further profiled.

Competitive developments, investments, strategic expansion and competitive landscape of the key players operating in the Global Bioabsorbable Stents Market are also profiled.

Global Bioabsorbable Stents Market Scope: Inquire before buying

Global Bioabsorbable Stents Market
Report Coverage Details
Base Year: 2022 Forecast Period: 2023-2029
Historical Data: 2018 to 2022 Market Size in 2022: US $ 323.82 Mn.
Forecast Period 2023 to 2029 CAGR: 7.35% Market Size in 2029: US $ 532.02 Mn.
Segments Covered: by Absorption rates Slow absorption stents
Fast absorption stents
by Drugs Paclitaxel
Limus based drugs
by Applications Coronary artery disease
Peripheral artery disease
by End-Users Hospitals
Cardiac centers
by Materials Polymeric Stents
Metallic Stents

Global Bioabsorbable Stents Market, by Region:

Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
North America (United States, Canada and Mexico)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)

Global Bioabsorbable Stents Market Key Players

1. 480 Biomedical
2. Abbott
3. Amaranth Medical Inc.
4. Arterial Remodeling Technologies
5. Arterius Limited
6. BIOTRONIK
7. Boston Scientific Corporation
8. Elixir Medical Corporation
9. HangZhou HuaAn Biotechnology Co., Ltd
10. KYOTO MEDICAL PLANNING Co. Ltd.
11. LEPU MEDICAL TECHNOLOGY CO. LTD.
12. Lifetech Scientific (Shenzhen) Co. Ltd
13. Manli Cardiology Ltd.
14. Meril Life Sciences Pvt. Ltd.
15. ORBUSNEICH
16. QualiMed
17. REVA Medical Inc.
18. S3V Vascular Technologies
19. SMT
20. TEPHA INC
21. Zorion Medical Inc

Frequently Asked Questions:

1. Which region has the largest share in Global Bioabsorbable Stents Market?
Ans: Asia Pacific region holds the highest share in 2022.

2. What is the growth rate of Global Bioabsorbable Stents Market?
Ans: The Global Bioabsorbable Stents Market is growing at a CAGR of 7.35% during forecasting period 2023-2029.

3. What is scope of the Global Bioabsorbable Stents market report?
Ans: Global Bioabsorbable Stents Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period.

4. Who are the key players in Global Bioabsorbable Stents market?
Ans: The important key players in the Global Bioabsorbable Stents Market are – 480 Biomedical, Abbott, Amaranth Medical Inc., Arterial Remodeling Technologies, Arterius Limited, BIOTRONIK, Boston Scientific Corporation, Elixir Medical Corporation, HangZhou HuaAn Biotechnology Co., Ltd, KYOTO MEDICAL PLANNING Co. Ltd., LEPU MEDICAL TECHNOLOGY CO. LTD., Lifetech Scientific (Shenzhen) Co. Ltd, Manli Cardiology Ltd., Meril Life Sciences Pvt. Ltd., ORBUSNEICH, QualiMed, REVA Medical Inc., S3V Vascular Technologies, SMT, TEPHA INC, and Zorion Medical Inc

5. What is the study period of this market?
Ans: The Global Bioabsorbable Stents Market is studied from 2022 to 2029.

Table of Contents

Global Bioabsorbable Stents Market

1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 1.4. Key Questions Answered 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations Used 2.3. Research Methodology 3. Executive Summary 3.1. Global Bioabsorbable Stents Market Size, by Market Value (US$ Mn) and Market, by Region 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.3. Drivers and Restraints Snapshot Analysis 4.3.1. Drivers 4.3.2. Restraints 4.3.3. Opportunities 4.3.4. Porter’s Analysis 4.3.5. Value Chain Analysis 4.3.6. SWOT Analysis 4.4. Global Bioabsorbable Stents Market Industry Trends 5. Global Bioabsorbable Stents Market Analysis and Forecast 5.1. Global Bioabsorbable Stents Market Analysis and Forecast 5.2. Global Bioabsorbable Stents Market Size & Y-o-Y Growth Analysis 5.2.1. North America 5.2.2. Europe 5.2.3. Asia Pacific 5.2.4. Middle East & Africa 5.2.5. Latin America 6. Global Bioabsorbable Stents Market Analysis and Forecast, by Absorption rates 6.1. Introduction and Definition 6.2. Key Findings 6.3. Global Bioabsorbable Stents Market Value Share Analysis, by Absorption rates 6.4. Global Bioabsorbable Stents Market Size (US$ Mn) Forecast, by Absorption rates 6.5. Global Bioabsorbable Stents Market Analysis, by Absorption rates 6.6. Global Bioabsorbable Stents Market Attractiveness Analysis, by Absorption rates 7. Global Bioabsorbable Stents Market Analysis and Forecast, by Drugs 7.1. Introduction and Definition 7.2. Global Bioabsorbable Stents Market Value Share Analysis, by Drugs 7.3. Global Bioabsorbable Stents Market Size (US$ Mn) Forecast, by Drugs 7.4. Global Bioabsorbable Stents Market Analysis, by Drugs 7.5. Global Bioabsorbable Stents Market Attractiveness Analysis, by Drugs 8. Global Bioabsorbable Stents Market Analysis and Forecast, by Applications 8.1. Introduction and Definition 8.2. Global Bioabsorbable Stents Market Value Share Analysis, by Applications 8.3. Global Bioabsorbable Stents Market Size (US$ Mn) Forecast, by Applications 8.4. Global Bioabsorbable Stents Market Analysis, by Applications 8.5. Global Bioabsorbable Stents Market Attractiveness Analysis, by Applications 9. Global Bioabsorbable Stents Market Analysis and Forecast, by End user 9.1. Introduction and Definition 9.2. Global Bioabsorbable Stents Market Value Share Analysis, by End user 9.3. Global Bioabsorbable Stents Market Size (US$ Mn) Forecast, by End user 9.4. Global Bioabsorbable Stents Market Analysis, by End user 9.5. Global Bioabsorbable Stents Market Attractiveness Analysis, by End user 10. Global Bioabsorbable Stents Market Analysis and Forecast, by Materials 10.1. Introduction and Definition 10.2. Global Bioabsorbable Stents Market Value Share Analysis, by Materials 10.3. Global Bioabsorbable Stents Market Size (US$ Mn) Forecast, by Materials 10.4. Global Bioabsorbable Stents Market Analysis, by Materials 10.5. Global Bioabsorbable Stents Market Attractiveness Analysis, by Materials 11. Global Bioabsorbable Stents Market Analysis, by Region 11.1. Global Bioabsorbable Stents Market Value Share Analysis, by Region 11.2. Global Bioabsorbable Stents Market Size (US$ Mn) Forecast, by Region 11.3. Global Bioabsorbable Stents Market Attractiveness Analysis, by Region 12. North America Bioabsorbable Stents Market Analysis 12.1. Key Findings 12.2. North America Bioabsorbable Stents Market Overview 12.3. North America Bioabsorbable Stents Market Value Share Analysis, by Absorption rates 12.4. North America Bioabsorbable Stents Market Forecast, by Absorption rates 12.4.1. Slow absorption stents 12.4.2. Fast absorption stents 12.5. North America Bioabsorbable Stents Market Value Share Analysis, by Drugs 12.6. North America Bioabsorbable Stents Market Forecast, by Drugs 12.6.1. Paclitaxel 12.6.2. Limus based drugs 12.7. North America Bioabsorbable Stents Market Value Share Analysis, by Applications 12.8. North America Bioabsorbable Stents Market Forecast, by Applications 12.8.1. Coronary artery disease 12.8.2. Peripheral artery disease 12.9. North America Bioabsorbable Stents Market Value Share Analysis, by End user 12.10. North America Bioabsorbable Stents Market Forecast, by End user 12.10.1. Hospitals 12.10.2. Cardiac centers 12.11. North America Bioabsorbable Stents Market Value Share Analysis, by Materials 12.12. North America Bioabsorbable Stents Market Forecast, by Materials 12.12.1. Polymeric Stents 12.12.2. Metallic Stents 12.13. North America Bioabsorbable Stents Market Value Share Analysis, by Country 12.14. North America Bioabsorbable Stents Market Forecast, by Country 12.14.1. U.S. 12.14.2. Canada 12.15. North America Bioabsorbable Stents Market Analysis, by Country 12.16. U.S. Bioabsorbable Stents Market Forecast, by Absorption rates 12.16.1. Slow absorption stents 12.16.2. Fast absorption stents 12.17. U.S. Bioabsorbable Stents Market Forecast, by Drugs 12.17.1. Paclitaxel 12.17.2. Limus based drugs 12.18. U.S. Bioabsorbable Stents Market Forecast, by Applications 12.18.1. Coronary artery disease 12.18.2. Peripheral artery disease 12.19. U.S. Bioabsorbable Stents Market Forecast, by End user 12.19.1. Hospitals 12.19.2. Cardiac centers 12.20. U.S. Bioabsorbable Stents Market Forecast, by Materials 12.20.1. Polymeric Stents 12.20.2. Metallic Stents 12.21. Canada Bioabsorbable Stents Market Forecast, by Absorption rates 12.21.1. Slow absorption stents 12.21.2. Fast absorption stents 12.22. Canada Bioabsorbable Stents Market Forecast, by Drugs 12.22.1. Paclitaxel 12.22.2. Limus based drugs 12.23. Canada Bioabsorbable Stents Market Forecast, by Applications 12.23.1. Coronary artery disease 12.23.2. Peripheral artery disease 12.24. Canada Bioabsorbable Stents Market Forecast, by End user 12.24.1. Hospitals 12.24.2. Cardiac centers 12.25. Canada Bioabsorbable Stents Market Forecast, by Materials 12.25.1. Polymeric Stents 12.25.2. Metallic Stents 12.26. North America Bioabsorbable Stents Market Attractiveness Analysis 12.26.1. By Absorption rates 12.26.2. By Drugs 12.26.3. By Applications 12.26.4. By End user 12.26.5. By Materials 12.27. PEST Analysis 13. Europe Bioabsorbable Stents Market Analysis 13.1. Key Findings 13.2. Europe Bioabsorbable Stents Market Overview 13.3. Europe Bioabsorbable Stents Market Value Share Analysis, by Absorption rates 13.4. Europe Bioabsorbable Stents Market Forecast, by Absorption rates 13.4.1. Slow absorption stents 13.4.2. Fast absorption stents 13.5. Europe Bioabsorbable Stents Market Value Share Analysis, by Drugs 13.6. Europe Bioabsorbable Stents Market Forecast, by Drugs 13.6.1. Paclitaxel 13.6.2. Limus based drugs 13.7. Europe Bioabsorbable Stents Market Value Share Analysis, by Applications 13.8. Europe Bioabsorbable Stents Market Forecast, by Applications 13.8.1. Coronary artery disease 13.8.2. Peripheral artery disease 13.9. Europe Bioabsorbable Stents Market Value Share Analysis, by End user 13.10. Europe Bioabsorbable Stents Market Forecast, by End user 13.10.1. Hospitals 13.10.2. Cardiac centers 13.11. Europe Bioabsorbable Stents Market Value Share Analysis, by Materials 13.12. Europe Bioabsorbable Stents Market Forecast, by Materials 13.12.1. Polymeric Stents 13.12.2. Metallic Stents 13.13. Europe Bioabsorbable Stents Market Value Share Analysis, by Country 13.14. Europe Bioabsorbable Stents Market Forecast, by Country 13.14.1. Germany 13.14.2. U.K. 13.14.3. France 13.14.4. Italy 13.14.5. Spain 13.14.6. Rest of Europe 13.15. Europe Bioabsorbable Stents Market Analysis, by Country/ Sub-region 13.16. Germany Bioabsorbable Stents Market Forecast, by Absorption rates 13.16.1. Slow absorption stents 13.16.2. Fast absorption stents 13.17. Germany Bioabsorbable Stents Market Forecast, by Drugs 13.17.1. Paclitaxel 13.17.2. Limus based drugs 13.18. Germany Bioabsorbable Stents Market Forecast, by Applications 13.18.1. Coronary artery disease 13.18.2. Peripheral artery disease 13.19. Germany Bioabsorbable Stents Market Forecast, by End user 13.19.1. Hospitals 13.19.2. Cardiac centers 13.20. Germany Bioabsorbable Stents Market Forecast, by Materials 13.20.1. Polymeric Stents 13.20.2. Metallic Stents 13.21. U.K. Bioabsorbable Stents Market Forecast, by Absorption rates 13.21.1. Slow absorption stents 13.21.2. Fast absorption stents 13.22. U.K. Bioabsorbable Stents Market Forecast, by Drugs 13.22.1. Paclitaxel 13.22.2. Limus based drugs 13.23. U.K. Bioabsorbable Stents Market Forecast, by Applications 13.23.1. Coronary artery disease 13.23.2. Peripheral artery disease 13.24. U.K. Bioabsorbable Stents Market Forecast, by End user 13.24.1. Hospitals 13.24.2. Cardiac centers 13.25. U.K. Bioabsorbable Stents Market Forecast, by Materials 13.25.1. Polymeric Stents 13.25.2. Metallic Stents 13.26. France Bioabsorbable Stents Market Forecast, by Absorption rates 13.26.1. Slow absorption stents 13.26.2. Fast absorption stents 13.27. France Bioabsorbable Stents Market Forecast, by Drugs 13.27.1. Paclitaxel 13.27.2. Limus based drugs 13.28. France Bioabsorbable Stents Market Forecast, by Applications 13.28.1. Coronary artery disease 13.28.2. Peripheral artery disease 13.29. France Bioabsorbable Stents Market Forecast, by End user 13.29.1. Hospitals 13.29.2. Cardiac centers 13.30. France Bioabsorbable Stents Market Forecast, by Materials 13.30.1. Polymeric Stents 13.30.2. Metallic Stents 13.31. Italy Bioabsorbable Stents Market Forecast, by Absorption rates 13.31.1. Slow absorption stents 13.31.2. Fast absorption stents 13.32. Italy Bioabsorbable Stents Market Forecast, by Drugs 13.32.1. Paclitaxel 13.32.2. Limus based drugs 13.33. Italy Bioabsorbable Stents Market Forecast, by Applications 13.33.1. Coronary artery disease 13.33.2. Peripheral artery disease 13.34. Italy Bioabsorbable Stents Market Forecast, by End user 13.34.1. Hospitals 13.34.2. Cardiac centers 13.35. Italy Bioabsorbable Stents Market Forecast, by Materials 13.35.1. Polymeric Stents 13.35.2. Metallic Stents 13.36. Spain Bioabsorbable Stents Market Forecast, by Absorption rates 13.36.1. Slow absorption stents 13.36.2. Fast absorption stents 13.37. Spain Bioabsorbable Stents Market Forecast, by Drugs 13.37.1. Paclitaxel 13.37.2. Limus based drugs 13.38. Spain Bioabsorbable Stents Market Forecast, by Applications 13.38.1. Coronary artery disease 13.38.2. Peripheral artery disease 13.39. Spain Bioabsorbable Stents Market Forecast, by End user 13.39.1. Hospitals 13.39.2. Cardiac centers 13.40. Spain Bioabsorbable Stents Market Forecast, by Materials 13.40.1. Polymeric Stents 13.40.2. Metallic Stents 13.41. Rest of Europe Bioabsorbable Stents Market Forecast, by Absorption rates 13.41.1. Slow absorption stents 13.41.2. Fast absorption stents 13.42. Rest of Europe Bioabsorbable Stents Market Forecast, by Drugs 13.42.1. Paclitaxel 13.42.2. Limus based drugs 13.43. Rest of Europe Bioabsorbable Stents Market Forecast, by Applications 13.43.1. Coronary artery disease 13.43.2. Peripheral artery disease 13.44. Rest Of Europe Bioabsorbable Stents Market Forecast, by End user 13.44.1. Hospitals 13.44.2. Cardiac centers 13.45. Rest Of Europe Bioabsorbable Stents Market Forecast, by Materials 13.45.1. Polymeric Stents 13.45.2. Metallic Stents 13.46. Europe Bioabsorbable Stents Market Attractiveness Analysis 13.46.1. By Absorption rates 13.46.2. By Drugs 13.46.3. By Applications 13.46.4. By End user 13.46.5. By Materials 13.47. PEST Analysis 14. Asia Pacific Bioabsorbable Stents Market Analysis 14.1. Key Findings 14.2. Asia Pacific Bioabsorbable Stents Market Overview 14.3. Asia Pacific Bioabsorbable Stents Market Value Share Analysis, by Absorption rates 14.4. Asia Pacific Bioabsorbable Stents Market Forecast, by Absorption rates 14.4.1. Slow absorption stents 14.4.2. Fast absorption stents 14.5. Asia Pacific Bioabsorbable Stents Market Value Share Analysis, by Drugs 14.6. Asia Pacific Bioabsorbable Stents Market Forecast, by Drugs 14.6.1. Paclitaxel 14.6.2. Limus based drugs 14.7. Asia Pacific Bioabsorbable Stents Market Value Share Analysis, by Applications 14.8. Asia Pacific Bioabsorbable Stents Market Forecast, by Applications 14.8.1. Coronary artery disease 14.8.2. Peripheral artery disease 14.9. Asia Pacific Bioabsorbable Stents Market Value Share Analysis, by End user 14.10. Asia Pacific Bioabsorbable Stents Market Forecast, by End user 14.10.1. Hospitals 14.10.2. Cardiac centers 14.11. Asia Pacific Bioabsorbable Stents Market Value Share Analysis, by Materials 14.12. Asia Pacific Bioabsorbable Stents Market Forecast, by Materials 14.12.1. Polymeric Stents 14.12.2. Metallic Stents 14.13. Asia Pacific Bioabsorbable Stents Market Value Share Analysis, by Country 14.14. Asia Pacific Bioabsorbable Stents Market Forecast, by Country 14.14.1. China 14.14.2. India 14.14.3. Japan 14.14.4. ASEAN 14.14.5. Rest of Asia Pacific 14.15. Asia Pacific Bioabsorbable Stents Market Analysis, by Country/ Sub-region 14.16. China Bioabsorbable Stents Market Forecast, by Absorption rates 14.16.1. Slow absorption stents 14.16.2. Fast absorption stents 14.17. China Bioabsorbable Stents Market Forecast, by Drugs 14.17.1. Paclitaxel 14.17.2. Limus based drugs 14.18. China Bioabsorbable Stents Market Forecast, by Applications 14.18.1. Coronary artery disease 14.18.2. Peripheral artery disease 14.19. China Bioabsorbable Stents Market Forecast, by End user 14.19.1. Hospitals 14.19.2. Cardiac centers 14.20. China Bioabsorbable Stents Market Forecast, by Materials 14.20.1. Polymeric Stents 14.20.2. Metallic Stents 14.21. India Bioabsorbable Stents Market Forecast, by Absorption rates 14.21.1. Slow absorption stents 14.21.2. Fast absorption stents 14.22. India Bioabsorbable Stents Market Forecast, by Drugs 14.22.1. Paclitaxel 14.22.2. Limus based drugs 14.23. India Bioabsorbable Stents Market Forecast, by Applications 14.23.1. Coronary artery disease 14.23.2. Peripheral artery disease 14.24. India Bioabsorbable Stents Market Forecast, by End user 14.24.1. Hospitals 14.24.2. Cardiac centers 14.25. India Bioabsorbable Stents Market Forecast, by Materials 14.25.1. Polymeric Stents 14.25.2. Metallic Stents 14.26. Japan Bioabsorbable Stents Market Forecast, by Absorption rates 14.26.1. Slow absorption stents 14.26.2. Fast absorption stents 14.27. Japan Bioabsorbable Stents Market Forecast, by Drugs 14.27.1. Paclitaxel 14.27.2. Limus based drugs 14.28. Japan Bioabsorbable Stents Market Forecast, by Applications 14.28.1. Coronary artery disease 14.28.2. Peripheral artery disease 14.29. Japan Bioabsorbable Stents Market Forecast, by End user 14.29.1. Hospitals 14.29.2. Cardiac centers 14.30. Japan Bioabsorbable Stents Market Forecast, by Materials 14.30.1. Polymeric Stents 14.30.2. Metallic Stents 14.31. ASEAN Bioabsorbable Stents Market Forecast, by Absorption rates 14.31.1. Slow absorption stents 14.31.2. Fast absorption stents 14.32. ASEAN Bioabsorbable Stents Market Forecast, by Drugs 14.32.1. Paclitaxel 14.32.2. Limus based drugs 14.33. ASEAN Bioabsorbable Stents Market Forecast, by Applications 14.33.1. Coronary artery disease 14.33.2. Peripheral artery disease 14.34. ASEAN Bioabsorbable Stents Market Forecast, by End user 14.34.1. Hospitals 14.34.2. Cardiac centers 14.35. ASEAN Bioabsorbable Stents Market Forecast, by Materials 14.35.1. Polymeric Stents 14.35.2. Metallic Stents 14.36. Rest of Asia Pacific Bioabsorbable Stents Market Forecast, by Absorption rates 14.36.1. Slow absorption stents 14.36.2. Fast absorption stents 14.37. Rest of Asia Pacific Bioabsorbable Stents Market Forecast, by Drugs 14.37.1. Paclitaxel 14.37.2. Limus based drugs 14.38. Rest of Asia Pacific Bioabsorbable Stents Market Forecast, by Applications 14.38.1. Coronary artery disease 14.38.2. Peripheral artery disease 14.39. Rest of Asia Pacific Bioabsorbable Stents Market Forecast, by End user 14.39.1. Hospitals 14.39.2. Cardiac centers 14.40. Rest of Asia Pacific Bioabsorbable Stents Market Forecast, by Materials 14.40.1. Polymeric Stents 14.40.2. Metallic Stents 14.41. Asia Pacific Bioabsorbable Stents Market Attractiveness Analysis 14.41.1. By Absorption rates 14.41.2. By Drugs 14.41.3. By Applications 14.41.4. By End user 14.41.5. By Materials 14.42. PEST Analysis 15. Middle East & Africa Bioabsorbable Stents Market Analysis 15.1. Key Findings 15.2. Middle East & Africa Bioabsorbable Stents Market Overview 15.3. Middle East & Africa Bioabsorbable Stents Market Value Share Analysis, by Absorption rates 15.4. Middle East & Africa Bioabsorbable Stents Market Forecast, by Absorption rates 15.4.1. Slow absorption stents 15.4.2. Fast absorption stents 15.5. Middle East & Africa Bioabsorbable Stents Market Value Share Analysis, by Drugs 15.6. Middle East & Africa Bioabsorbable Stents Market Forecast, by Drugs 15.6.1. Paclitaxel 15.6.2. Limus based drugs 15.7. Middle East & Africa Bioabsorbable Stents Market Value Share Analysis, by Applications 15.8. Middle East & Africa Bioabsorbable Stents Market Forecast, by Applications 15.8.1. Coronary artery disease 15.8.2. Peripheral artery disease 15.9. Middle East & Africa Bioabsorbable Stents Market Value Share Analysis, by End user 15.10. Middle East & Africa Bioabsorbable Stents Market Forecast, by End user 15.10.1. Hospitals 15.10.2. Cardiac centers 15.11. Middle East & Africa Bioabsorbable Stents Market Value Share Analysis, by Materials 15.12. Middle East & Africa Bioabsorbable Stents Market Forecast, by Materials 15.12.1. Polymeric Stents 15.12.2. Metallic Stents 15.13. Middle East & Africa Bioabsorbable Stents Market Value Share Analysis, by Country 15.14. Middle East & Africa Bioabsorbable Stents Market Forecast, by Country 15.14.1. GCC 15.14.2. South Africa 15.14.3. Rest of Middle East & Africa 15.15. Middle East & Africa Bioabsorbable Stents Market Analysis, by Country/ Sub-region 15.16. GCC Bioabsorbable Stents Market Forecast, by Absorption rates 15.16.1. Slow absorption stents 15.16.2. Fast absorption stents 15.17. GCC Bioabsorbable Stents Market Forecast, by Drugs 15.17.1. Paclitaxel 15.17.2. Limus based drugs 15.18. GCC Bioabsorbable Stents Market Forecast, by Applications 15.18.1. Coronary artery disease 15.18.2. Peripheral artery disease 15.19. GCC Bioabsorbable Stents Market Forecast, by End user 15.19.1. Hospitals 15.19.2. Cardiac centers 15.20. GCC Bioabsorbable Stents Market Forecast, by Materials 15.20.1. Polymeric Stents 15.20.2. Metallic Stents 15.21. South Africa Bioabsorbable Stents Market Forecast, by Absorption rates 15.21.1. Slow absorption stents 15.21.2. Fast absorption stents 15.22. South Africa Bioabsorbable Stents Market Forecast, by Drugs 15.22.1. Paclitaxel 15.22.2. Limus based drugs 15.23. South Africa Bioabsorbable Stents Market Forecast, by Applications 15.23.1. Coronary artery disease 15.23.2. Peripheral artery disease 15.24. South Africa Bioabsorbable Stents Market Forecast, by End user 15.24.1. Hospitals 15.24.2. Cardiac centers 15.25. South Africa Bioabsorbable Stents Market Forecast, by Materials 15.25.1. Polymeric Stents 15.25.2. Metallic Stents 15.26. Rest of Middle East & Africa Bioabsorbable Stents Market Forecast, by Absorption rates 15.26.1. Slow absorption stents 15.26.2. Fast absorption stents 15.27. Rest of Middle East & Africa Bioabsorbable Stents Market Forecast, by Drugs 15.27.1. Paclitaxel 15.27.2. Limus based drugs 15.28. Rest of Middle East & Africa Bioabsorbable Stents Market Forecast, by Applications 15.28.1. Coronary artery disease 15.28.2. Peripheral artery disease 15.29. Rest of Middle East & Africa Bioabsorbable Stents Market Forecast, by End user 15.29.1. Hospitals 15.29.2. Cardiac centers 15.30. Rest of Middle East & Africa Bioabsorbable Stents Market Forecast, by Materials 15.30.1. Polymeric Stents 15.30.2. Metallic Stents 15.31. Middle East & Africa Bioabsorbable Stents Market Attractiveness Analysis 15.31.1. By Absorption rates 15.31.2. By Drugs 15.31.3. By Applications 15.31.4. By End user 15.31.5. By Materials 15.32. PEST Analysis 16. Latin America Bioabsorbable Stents Market Analysis 16.1. Key Findings 16.2. Latin America Bioabsorbable Stents Market Overview 16.3. Latin America Bioabsorbable Stents Market Value Share Analysis, by Absorption rates 16.4. Latin America Bioabsorbable Stents Market Forecast, by Absorption rates 16.4.1. Slow absorption stents 16.4.2. Fast absorption stents 16.5. Latin America Bioabsorbable Stents Market Value Share Analysis, by Drugs 16.6. Latin America Bioabsorbable Stents Market Forecast, by Drugs 16.6.1. Paclitaxel 16.6.2. Limus based drugs 16.7. Latin America Bioabsorbable Stents Market Value Share Analysis, by Applications 16.8. Latin America Bioabsorbable Stents Market Forecast, by Applications 16.8.1. Coronary artery disease 16.8.2. Peripheral artery disease 16.9. Latin America Bioabsorbable Stents Market Value Share Analysis, by End user 16.10. Latin America Bioabsorbable Stents Market Forecast, by End user 16.10.1. Hospitals 16.10.2. Cardiac centers 16.11. Latin America Bioabsorbable Stents Market Value Share Analysis, by Materials 16.12. Latin America Bioabsorbable Stents Market Forecast, by Materials 16.12.1. Polymeric Stents 16.12.2. Metallic Stents 16.13. Latin America Bioabsorbable Stents Market Value Share Analysis, by Country 16.14. Latin America Bioabsorbable Stents Market Forecast, by Country 16.14.1. Brazil 16.14.2. Mexico 16.14.3. Rest of Latin America 16.15. Latin America Bioabsorbable Stents Market Analysis, by Country/ Sub-region 16.16. Brazil Bioabsorbable Stents Market Forecast, by Absorption rates 16.16.1. Slow absorption stents 16.16.2. Fast absorption stents 16.17. Brazil Bioabsorbable Stents Market Forecast, by Drugs 16.17.1. Paclitaxel 16.17.2. Limus based drugs 16.18. Brazil Bioabsorbable Stents Market Forecast, by Applications 16.18.1. Coronary artery disease 16.18.2. Peripheral artery disease 16.19. Brazil Bioabsorbable Stents Market Forecast, by End user 16.19.1. Hospitals 16.19.2. Cardiac centers 16.20. Brazil Bioabsorbable Stents Market Forecast, by Materials 16.20.1. Polymeric Stents 16.20.2. Metallic Stents 16.21. Mexico Bioabsorbable Stents Market Forecast, by Absorption rates 16.21.1. Slow absorption stents 16.21.2. Fast absorption stents 16.22. Mexico Bioabsorbable Stents Market Forecast, by Drugs 16.22.1. Paclitaxel 16.22.2. Limus based drugs 16.23. Mexico Bioabsorbable Stents Market Forecast, by Applications 16.23.1. Coronary artery disease 16.23.2. Peripheral artery disease 16.24. Mexico Bioabsorbable Stents Market Forecast, by End user 16.24.1. Hospitals 16.24.2. Cardiac centers 16.25. Mexico Bioabsorbable Stents Market Forecast, by Materials 16.25.1. Polymeric Stents 16.25.2. Metallic Stents 16.26. Rest of Latin America Bioabsorbable Stents Market Forecast, by Absorption rates 16.26.1. Slow absorption stents 16.26.2. Fast absorption stents 16.27. Rest of Latin America Bioabsorbable Stents Market Forecast, by Drugs 16.27.1. Paclitaxel 16.27.2. Limus based drugs 16.28. Rest of Latin America Bioabsorbable Stents Market Forecast, by Applications 16.28.1. Coronary artery disease 16.28.2. Peripheral artery disease 16.29. Rest of Latin America Bioabsorbable Stents Market Forecast, by End user 16.29.1. Hospitals 16.29.2. Cardiac centers 16.30. Rest of Latin America Bioabsorbable Stents Market Forecast, by Materials 16.30.1. Polymeric Stents 16.30.2. Metallic Stents 16.31. Latin America Bioabsorbable Stents Market Attractiveness Analysis 16.31.1. By Absorption rates 16.31.2. By Drugs 16.31.3. By Applications 16.31.4. By End users 16.31.5. By Materials 16.32. PEST Analysis 17. Company Profiles 17.1. Market Share Analysis, by Company 17.2. Competition Matrix 17.3. Company Profiles: Key Players 17.3.1. SMT 17.3.1.1. Company Overview 17.3.1.2. Financial Overview 17.3.1.3. Business Strategy 17.3.1.4. Recent Developments 17.3.1.5. Manufacturing Footprint 17.3.2. 480 Biomedical 17.3.3. Abbott 17.3.4. Amaranth Medical Inc. 17.3.5. Arterial Remodeling Technologies 17.3.6. Arterius Limited 17.3.7. BIOTRONIK 17.3.8. Boston Scientific Corporation 17.3.9. Elixir Medical Corporation 17.3.10. HangZhou HuaAn Biotechnology Co.,Ltd 17.3.11. KYOTO MEDICAL PLANNING Co. Ltd. 17.3.12. LEPU MEDICAL TECHNOLOGY CO. LTD. 17.3.13. Lifetech Scientific (Shenzhen) Co. Ltd 17.3.14. Manli Cardiology Ltd. 17.3.15. Meril Life Sciences Pvt. Ltd. 17.3.16. ORBUSNEICH 17.3.17. QualiMed 17.3.18. REVA Medical Inc. 17.3.19. S3V Vascular Technologies 17.3.20. TEPHA INC 17.3.21. Zorion Medical Inc 18. Primary Key Insights

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Request Customization Download Sample